My research interests are understanding how and why exercise is effective in chronic disease. I am interested in the unique role of skeletal muscle as a key mediator of exercise effects.
Glass, O, Radia, A, Kraus, W, and Abdelmalek, M. "Exercise Training as Treatment of Nonalcoholic Fatty Liver Disease." Journal of Functional Morphology and Kinesiology 2, no. 4 (December 2017): 35-35.
Glass, OK, Bowie, M, Fuller, J, Darr, D, Usary, J, Boss, K, Choudhury, KR, Liu, X, Zhang, Z, Locasale, JW, Williams, C, Dewhirst, MW, Jones, LW, and Seewaldt, V. "Differential response to exercise in claudin-low breast cancer." Oncotarget 8, no. 60 (November 2017): 100989-101004.
Glass, OK, Ramalingam, S, and Harrison, MR. "Resistance exercise training in patients with genitourinary cancers to mitigate treatment-related skeletal muscle loss." Clinical advances in hematology & oncology : H&O 14, no. 6 (June 2016): 436-446. (Review)
Glass, OK, Inman, BA, Broadwater, G, Courneya, KS, Mackey, JR, Goruk, S, Nelson, ER, Jasper, J, Field, CJ, Bain, JR, Muehlbauer, M, Stevens, RD, Hirschey, MD, and Jones, LW. "Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study." British journal of cancer 112, no. 5 (March 2015): 825-831.
Glass, O, Inman, BA, Courneya, KS, Mackey, JR, Nelson, E, Hartman, Z, and Jones, LW. "Abstract 1376: Exercise alters breast cancer phenotype through distinct reductions in host-derived proinflammatory growth factor ligands." April 15, 2013.
Hartman, ZC, Wei, J, Glass, OK, Guo, H, Lei, G, Yang, X-Y, Osada, T, Hobeika, A, Delcayre, A, Le Pecq, J-B, Morse, MA, Clay, TM, and Lyerly, HK. "Increasing vaccine potency through exosome antigen targeting." Vaccine 29, no. 50 (November 21, 2011): 9361-9367.
Hartman, ZC, Yang, X-Y, Glass, O, Lei, G, Osada, T, Dave, SS, Morse, MA, Clay, TM, and Lyerly, HK. "HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis." Cancer Res 71, no. 13 (July 1, 2011): 4380-4391.
Hartman, ZC, Osada, T, Glass, O, Yang, XY, Lei, G-J, Lyerly, HK, and Clay, TM. "Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity." Cancer Res 70, no. 18 (September 15, 2010): 7209-7220.
Hartman, ZC, Wei, J, Osada, T, Glass, O, Lei, G, Yang, X-Y, Peplinski, S, Kim, D-W, Xia, W, Spector, N, Marks, J, Barry, W, Hobeika, A, Devi, G, Amalfitano, A, Morse, MA, Lyerly, HK, and Clay, TM. "An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity." Clin Cancer Res 16, no. 5 (March 1, 2010): 1466-1477.
Osada, T, Yang, XY, Hartman, ZC, Glass, O, Hodges, BL, Niedzwiecki, D, Morse, MA, Lyerly, HK, Amalfitano, A, and Clay, TM. "Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity." Cancer Gene Ther 16, no. 9 (September 2009): 673-682.